期刊文献+

高龄妊娠期糖尿病患者血清miR-351,FGF19和LP-PLA2表达水平及其与产后糖代谢异常的相关性研究 被引量:5

Serum miR-351,FGF19 and LP-PLA2 Expression Levels in Elderly Patients with Gestational Diabetes Mellitus and Their Correlation with Abnormal Postpartum Glucose Metabolism
下载PDF
导出
摘要 目的探讨高龄妊娠期糖尿病(gestational diabetes mellitus,GDM)患者微小核糖核酸(micro RNA,mi R)-351,纤维细胞生长因子19(fibroblast growth factor 19,FGF19),脂蛋白相关磷脂酶A2(lipoprotein-associated phospholipase A2,LP-PLA2)表达及与产后糖代谢异常的相关性。方法选取2019年1月~2022年1月唐山市妇幼保健院高龄GDM患者86例为观察组,同期选取产检的正常高龄孕妇52例为对照组。比较两组血清mi R-351,FGF19和LP-PLA2表达,分析高龄GDM患者mi R-351,FGF19和LP-PLA2与产后糖脂代谢指标相关性,Logistic回归分析高龄GDM患者产后糖代谢异常影响因素,受试者工作特征(ROC)分析mi R-351,FGF19和LP-PLA2对产后糖代谢异常预测价值。结果观察组血清空腹血糖(FPG)(5.93±0.61mmol/L),空腹胰岛素(FINS)(15.82±4.19m U/L),胰岛素抵抗指数(MOHA-IR)(4.31±0.64),三酰甘油(TG)(1.46±0.28mmol/L),低密度酯蛋白-胆固醇(LDL-C)(2.93±0.66mmol/L),mi R-351(6.42±1.76),LP-PLA2活性(33.09±6.51nmol/min·ml)高于对照组(4.48±0.76mmol/L,11.65±3.90m/U/L,2.45±0.57,1.32±0.24mmol/L,2.58±0.59mmol/L,3.79±1.14,24.52±5.83nmol/min·ml),而FGF19(91.18±8.64ng/L)水平低于对照组(122.63±10.29ng/L),差异均有统计学意义(t=2.999~17.226,均P<0.05);高龄GDM患者血清mi R-351水平、LP-PLA2活性与空腹血糖(fasting plasma glucose,FPG)、空腹胰岛素(fasting insulin,FINS)、胰岛素抵抗指数(insulin resistance index,HOMA-IR)、三酰甘油(triglyceride,TG)和低密度脂蛋白-胆固醇(low density lipoprotein,LDL-C)呈正相关(r=0.408~0.584,均P<0.05),血清FGF19水平与FPG,FINS和HOMA-IR呈负相关(r=-0.614~-0.386,均P<0.05);高龄GDM患者mi R-351与FGF19呈负相关(r=-0.531,P<0.001),与LPPLA2呈正相关(r=0.549,P<0.001),FGF19与LP-PLA2呈负相关(r=-0.614,P<0.001)。Logistic回归模型分析显示,mi R-351,LP-PLA2活性升高及FGF19降低均为高龄GDM患者产后糖代谢异常独立危险因素(P<0.05);ROC曲线显示,mi R-351,LP-PLA2和FGF19对GDM患者产后糖代谢 Objective To investigate the microRNA(miR)-351,fibroblast growth factor 19(FGF19)and lipoprotein-associated phospholipase A2(LP-PLA2)in elderly patients with gestational diabetes mellitus(GDM)expression and its correlation with abnormal postpartum glucose metabolism.Methods From January 2019 to January 2022,86 elderly patients with GDM in Tangshan Maternal and Child Health Hospital were selected as the observation group,and 52 normal elderly pregnant women who underwent obstetric examination in the hospital during the same period were selected as the control group.The clinical characteristics and serum miR-351,FGF19 and LP-PLA2 expressions were compared between the two groups.The correlation between miR-351,FGF19,LP-PLA2 and postpartum glucose and lipid metabolism indexes in elderly GDM patients was analyzed.Logistic regression was used to analyze postpartum glucose metabolism abnormalities in elderly GDM patients.Influencing factors,receiver operating characteristic(ROC)analysis of the predictive value of miR-351,FGF19 and LP-PLA2 for abnormal postpartum glucose metabolism.Results Fasting plasma glucose(FPG)of observation group(5.93±0.61mmo/L vs 4.48±0.76mmol/L),fasting insulin(FINS)(15.8±4.19mU/L vs 11.65±3.90m/U/L),insulin resistance index(HOMA-IR)(4.31±0.64 vs 2.45±0.57),triglyceride(TG)(1.46±0.28mmol/L vs 1.32±0.24mmol/L),low density lipoprotein-C(LDL-C)(2.93±0.66mmol/L vs 2.58±0.59mmol/L),serum miR-351(6.42±1.76 vs 3.79±1.14),LP-PLA2 activity(33.09±6.51nmol/min·ml vs 24.52±5.83nmol/min·ml)was higher than the control group,FGF19 level(91.18±8.64ng/L vs 122.63±10.29ng/L)level was lower than the control group,the differences were statistically significant(t=2.999~17.226,all P<0.05).Serum miR-351 level and LP-PLA2 activity in elderly patients with GDM were positively correlated with FPG,FINS,HOMA-IR,TG and LDL-C(r=0.408~0.584,all P<0.05).Serum FGF19 level was negatively correlated with FPG,FINS,HOMA-IR(r=-0.614~-0.386,all P<0.05),miR-351 was negatively correlated with FGF19 in elderly GDM pati
作者 张东方 王茜 李娟 庄敏敏 ZHANG Dong-fang;WANG Qian;LI Juan;ZHUANG Min-min(Department of Obstetrics,Tangshan Maternal and Child Health Hospital,Hebei Tangshan 063000,China)
出处 《现代检验医学杂志》 CAS 2023年第1期66-72,共7页 Journal of Modern Laboratory Medicine
基金 河北省医学科学研究课题计划项目(20221770)。
关键词 高龄孕妇 妊娠期糖尿病 微小核糖核酸-351 纤维细胞生长因子19 脂蛋白相关磷脂酶A2 advanced maternal gestational diabetes mellitus microRNA-351 fibroblast growth factor 19 lipoproteinassociated phospholipase A2
  • 相关文献

参考文献16

二级参考文献129

  • 1Kahn CR.Joslin糖尿病学[M].14版.潘长玉,主译.北京:人民卫生出版社,2005:550-552. 被引量:1
  • 2Buchan JR, Parker R. The two faces of miRNA[J]. Scien- ce,2007,318(21) : 1 877. 被引量:1
  • 3Li J, Yao B, Huang H, et al. Real-time polymerase chain reaction microRNA detection based on enzymatic stem- loop probes ligation[J]. Anal Chem, 2009,81 (31 ) : 5 446. 被引量:1
  • 4Chitwood DH, Timmermans MC. Small RNAs are on the move[J]. Nature,2010,467(7 314) :415. 被引量:1
  • 5Zaragosi LE, Wdziekonski B, Brigand KL, et al. Small RNA sequencing reveals miR-642a-3p as a novel adipo- cyte-specific microRNA and miR-30 as a key regulator of human adipogenesis[J]. Genome Biol, 2011,12 (7) : R64. 被引量:1
  • 6Yi C, Xie WD, Li F, et al. MiR-143 enhances adipogenic differentiation of 3T3-L1 cells through targeting the cod- ing region of mouse pleiotrophin[J]. FEBS Lett, 2011,585 (20) :3 303. 被引量:1
  • 7Wang Q, Li YC, Wang J,et al. miR-17-92 cluster acceler- ates adipocyte differentiation by negatively regulating tu- mor-suppressor Rb2/p130[J]. Proc Natl Acad Sci U S A, 2008,105(8) :2 889. 被引量:1
  • 8Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease[J]. Cell, 2012,148(6) : 1 172. 被引量:1
  • 9Bartel DP. MicroRNAs: target recognition and regulatory functions[J]. Cell, 2009,136 (2) : 215. 被引量:1
  • 10Lindow M, Kauppinen S. Discovering the first microR- NA-targeted drug[J]. J Cell B iol, 2012,199 ( 3 ) : 407. 被引量:1

共引文献1589

同被引文献72

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部